(Q34793022)

4 August 2017

1 reference

title

Role of genetic and epigenetic changes in Burkitt lymphoma (English)

1 reference

4 August 2017

0 references

1 reference

Mikael S Lindström

1

1 reference

PubMed ID

12191637

4 August 2017

Klas G Wiman

series ordinal

2

1 reference

4 August 2017

1 October 2002

1 reference

Seminars in Cancer Biology

4 August 2017

1 reference

4 August 2017

12

1 reference

4 August 2017

381-387

1 reference

4 August 2017

5

1 reference

Molecular biology of Burkitt's lymphoma

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Inactivation of Myc-induced p53-dependent apoptosis in human tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

E2F transcriptional activation requires TRRAP and GCN5 cofactors

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Myc activates telomerase

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

p53-induced apoptosis as a safeguard against cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Tumor surveillance via the ARF-p53 pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Biological activities of p53 mutants in Burkitt's lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Mediation of c-Myc-induced apoptosis by p53.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

The INK4a/ARF network in tumour suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Immunolocalization of human p14(ARF) to the granular component of the interphase nucleolus

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Twist is a potential oncogene that inhibits apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Burkitt lymphoma in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

DAP kinase-a proapoptotic gene that functions as a tumor suppressor

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Role of p73 in malignancy: tumor suppressor or oncogene?

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Role for the p53 homologue p73 in E2F-1-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Point mutations of the BCL-6 gene in Burkitt's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Loss of functional pRB is not a ubiquitous feature of B-cell malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Dysregulation of lymphocyte proliferation by chromosomal translocations and sequential genetic changes

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

The role of EBERs in oncogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900058-5

7 January 2021

10.1016/S1044-579X(02)00058-5

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12191637